# SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

> **NCT02307604** · — · WITHDRAWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Brain Neoplasms

## Interventions

- **GENETIC:** Tumour markers testing

## Key facts

- **NCT ID:** NCT02307604
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study has been merged with 1553 SPECTA, in which brain patients are enrolled
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307604, "SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02307604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*